American Academy of Family Physicians

Printer-friendly version

Share this on AAFP Connection

Share this page

Dosing System Problems Prompt Recall of Infants' Tylenol Oral Suspension

By News Staff

McNeil Consumer Healthcare is voluntarily recalling more than half a million bottles of its Infants' Tylenol Oral Suspension, 1 oz. Grape, after parents complained that the product's new dosing system is difficult to use and may malfunction.
Stock photo of Infants' Tylenol package label
The system, dubbed SimpleMeasure, includes a dosing syringe that parents insert into a flow restrictor at the top of the bottle to ensure the proper dose is dispensed. In some cases, however, the flow restrictor is pushed into the bottle when the syringe is inserted.

More information about the products recalled, including the affected lot numbers and Universal Product Code, is available on McNeil's Tylenol website.

No adverse events have been reported to date as a result of this issue, and the risk of adverse events is remote, according to McNeil. Parents and caregivers can continue to use the product if the flow restrictor stays in place when the syringe is inserted. But if the flow restrictor becomes dislodged, the product should not be used.

The manufacturer has provided specific guidance on using the dosing system on its product website.

The problem affects only this particular Infants' Tylenol product; Children's Tylenol products, which use a different dosing system, are not included in the current recall.

Consumers may request a refund online or by contacting McNeil at (888) 222-6036 (Monday-Friday, 8 a.m.-8 p.m. EST; Saturday-Sunday, 9 a.m.-5 p.m. EST).


Share this on AAFP Connection

Search AAFP News Now

 

Health of the Public

AAFP, USPSTF Recommend Against Routine PSA Screening

Inadequate, Disordered Sleep Increases Diabetes Risk

Text Messaging Could Hike Vaccination Rates

Fluoroquinolones Tied to Greater Retinal Detachment Risk

Sanofi Announces DTaP Vaccine Shortage

AHRQ Resources Provide Ready Access to Research Data

Community-onset C. difficile Infections on the Rise

New FamilyDoctor.org Content Helps With Caring for Elderly

U.S. Measles Cases in 2011 Highest in 15 Years

FDA Warns of More Finasteride Side Effects

'Take-Back' Initiative Focuses on Destroying Unwanted Drugs

Bariatric Surgery May Help Combat Type 2 Diabetes

Certain Skin Products Tied to Mercury Poisoning

FDA Clarifies Citalopram Usage, Dosing Warnings

Veterans With PTSD at Heightened Risk for Opioid Abuse

ACP Releases Guideline on Type 2 Diabetes Management

Office Champions Seeking Applicants for Second Wave

Surgeon General Releases Report on Teen Smoking

USPSTF Issues Final Cervical Cancer Screening Recommendations

FDA Approves First Quadrivalent Influenza Vaccine

Survey: Physicians May Have Trouble Interpreting Cancer Statistics

AIM-HI Nutrition Questionnaire Can Open Dialogue

Statin, HIV/Hepatitis C Drug Interactions May Pose Risks

Statin Therapy Effective in Both Genders, Study Suggests

AAFP, CDC Announce Immunization Schedule Change

Family Physicians on Front Lines of Caring for Vets

ACIP Votes to Expand Tdap Recommendation

Recalled Oral Contraceptives Pose Pregnancy Risk

Studies Shed Light on Vaccine Side Effect Risks

Dosing Problems Prompt Recall of Infants' Tylenol Products

TB 'Superbug' Not Stateside Threat, Says FP

Adult Vaccination Coverage Remains Low, Says CDC

FDA Warns of Health Risk Tied to PPI Use

Study: PPI Does Not Routinely Improve Asthma Control

Recalled Oral Contraceptives Pose Pregnancy Risk

CDC to Fund 2D Vaccine Barcoding Pilot

2012 Immunization Schedules Reflect Multiple Changes

Study: Cognitive Decline Detected in Middle-aged Adults

CDC Toolkit Can Help Clinicians Fight Norovirus Infection

Patient-Centered Care Linked to Lower Mortality

Study: Inappropriate Cancer Screenings Continue

Novartis Manufacturing Plant Closes After Drug Mix-ups

FDA Announces Classwide REMS for TIRF Medications